Design and structure–activity relationship of a potent furin inhibitor derived from influenza hemagglutinin
Monika Lewandowska-Goch, Anna Kwiatkowska, Teresa Łepek, Kévin Ly, Navals Pauline, Gagnon Hugo, Yves Dory, Adam Prahl, Robert Day
ACS Medicinal Chemistry Letters, 2021, 12(3), 365-372. DOI:10.1021/acsmedchemlett.0c00386
Is the use of surface-enhanced infrared spectroscopy justified in the selection of peptide fragments that play a role in substrate–receptor interactions? Adsorption of amino acids and neurotransmitters on colloidal Ag and Au nanoparticles
Edyta Proniewicz, A. Ta̧ta, Emilia Iłowska, Adam Prahl
Journal of Physical Chemistry B, 2021, 125(99), 2328-2338. DOI:10.1021/acs.jpcb.1c00546
Positional scanning identifies the molecular determinants of a high affinity multi-leucine inhibitor for furin and PACE4
Izabela Małuch, Christine Levesque, Anna Kwiatkowska, Frédéric Couture, Kévin Ly, Roxane Desjardins, Witold Neugebauer, Adam Prahl, Robert Day
Journal of Medicinal Chemistry, 2017, 60(7), 2732-2744. DOI:10.1021/acs.jmedchem.6b01499
Design, synthesis, and structure-activity relationship studies of a potent PACE4 inhibitor
Anna Kwiatkowska, Frédéric Couture, Christine Levesque, Kévin Ly, Roxane Desjardins, Sophie Beauchemin, Adam Prahl, Bernard Lammek, Witold Neugebauer, Yves L. Dory, Robert Day
Journal of Medicinal Chemistry, 2014, 57(1), 98-109. DOI:10.1021/jm401457n
The multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells
Christine Levesque, Martin Fugère, Anna Kwiatkowska, Frederick Couture, Roxane Desjardins, Sophie Routhier, Philippe Moussette, Adam Prahl, Bernard Lammek, Jon R. Appel, Richard A. Houghten, Francois D'Anjou, Yves Dory, Witold Neugebauer, Robert Day
Journal of Medicinal Chemistry, 2012, 55(23), 10501-10511. DOI:10.1021/jm3011178